| pubmed-article:10919040 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10919040 | lifeskim:mentions | umls-concept:C0019163 | lld:lifeskim |
| pubmed-article:10919040 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:10919040 | lifeskim:mentions | umls-concept:C0085295 | lld:lifeskim |
| pubmed-article:10919040 | lifeskim:mentions | umls-concept:C0034819 | lld:lifeskim |
| pubmed-article:10919040 | lifeskim:mentions | umls-concept:C1749467 | lld:lifeskim |
| pubmed-article:10919040 | lifeskim:mentions | umls-concept:C0524909 | lld:lifeskim |
| pubmed-article:10919040 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:10919040 | pubmed:issue | 33 | lld:pubmed |
| pubmed-article:10919040 | pubmed:dateCreated | 2000-12-7 | lld:pubmed |
| pubmed-article:10919040 | pubmed:abstractText | In the current investigation, we evaluated patients with hepatitis B infection to determine whether serum soluble interleukin-2 receptor and interleukin-10 levels were changed and whether the degree of these changes in serum levels correlated with histologic severity of hepatitis related liver injury. | lld:pubmed |
| pubmed-article:10919040 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10919040 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10919040 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10919040 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10919040 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10919040 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10919040 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10919040 | pubmed:issn | 0172-6390 | lld:pubmed |
| pubmed-article:10919040 | pubmed:author | pubmed-author:TürkyilmazRR | lld:pubmed |
| pubmed-article:10919040 | pubmed:author | pubmed-author:TülekNN | lld:pubmed |
| pubmed-article:10919040 | pubmed:author | pubmed-author:SaglamMM | lld:pubmed |
| pubmed-article:10919040 | pubmed:author | pubmed-author:YildizMM | lld:pubmed |
| pubmed-article:10919040 | pubmed:author | pubmed-author:SaglamS KSK | lld:pubmed |
| pubmed-article:10919040 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10919040 | pubmed:volume | 47 | lld:pubmed |
| pubmed-article:10919040 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10919040 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10919040 | pubmed:pagination | 828-31 | lld:pubmed |
| pubmed-article:10919040 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:10919040 | pubmed:meshHeading | pubmed-meshheading:10919040... | lld:pubmed |
| pubmed-article:10919040 | pubmed:meshHeading | pubmed-meshheading:10919040... | lld:pubmed |
| pubmed-article:10919040 | pubmed:meshHeading | pubmed-meshheading:10919040... | lld:pubmed |
| pubmed-article:10919040 | pubmed:meshHeading | pubmed-meshheading:10919040... | lld:pubmed |
| pubmed-article:10919040 | pubmed:meshHeading | pubmed-meshheading:10919040... | lld:pubmed |
| pubmed-article:10919040 | pubmed:meshHeading | pubmed-meshheading:10919040... | lld:pubmed |
| pubmed-article:10919040 | pubmed:meshHeading | pubmed-meshheading:10919040... | lld:pubmed |
| pubmed-article:10919040 | pubmed:meshHeading | pubmed-meshheading:10919040... | lld:pubmed |
| pubmed-article:10919040 | pubmed:meshHeading | pubmed-meshheading:10919040... | lld:pubmed |
| pubmed-article:10919040 | pubmed:meshHeading | pubmed-meshheading:10919040... | lld:pubmed |
| pubmed-article:10919040 | pubmed:meshHeading | pubmed-meshheading:10919040... | lld:pubmed |
| pubmed-article:10919040 | pubmed:meshHeading | pubmed-meshheading:10919040... | lld:pubmed |
| pubmed-article:10919040 | pubmed:meshHeading | pubmed-meshheading:10919040... | lld:pubmed |
| pubmed-article:10919040 | pubmed:articleTitle | Soluble interleukin-2 receptor and interleukin-10 levels in patients with chronic hepatitis B infection. | lld:pubmed |
| pubmed-article:10919040 | pubmed:affiliation | Department of Clinical Microbiology and Immunology, Social Security Ankara Training Hospital, Turkey. | lld:pubmed |
| pubmed-article:10919040 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10919040 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10919040 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10919040 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10919040 | lld:pubmed |
